Radiotherapy in metastatic bladder cancer - Takeaways - MDSpire

Radiotherapy in metastatic bladder cancer

  • By

  • Sophie Ashley

  • Ananya Choudhury

  • Peter Hoskin

  • YeePei Song

  • Priyamvada Maitre

  • January 20, 2024

  • 0 min

Share

  • 1

    Bladder cancer causes nearly 200,000 deaths annually worldwide, with 10-15% of patients presenting with metastatic disease.

  • 2

    First-line treatment for metastatic bladder cancer includes platinum-based chemotherapy, with cisplatin and gemcitabine recommended for patients with good renal function.

  • 3

    Radiotherapy effectively alleviates symptoms like pelvic pain and haematuria in metastatic bladder cancer, often requiring 1-5 treatment fractions.

  • 4

    Stereotactic ablative radiotherapy (SABR) shows promise for treating oligometastatic bladder cancer, potentially prolonging disease control.

  • 5

    Patient selection is crucial for palliative radiotherapy, as performance status and disease stage significantly influence treatment outcomes.

Original Source(s)

Radiotherapy in metastatic bladder cancer

  • by Sophie Ashley, Ananya Choudhury, Peter Hoskin, YeePei Song, Priyamvada Maitre

  • January 20, 2024

Related Content

More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine

Boston magazine has named more than 145 physicians affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide. Drawing from a Castle Connolly Medical Ltd. physician database, the Boston magazine Top Doctors™ list draws from hundreds of Boston-area physicians in many medical specialties

  • by

  • January 27, 2026

  • 6 min
State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature

Influence of PSA level at salvage radiotherapy on metastasis-free survival following radical prostatectomy